Investigating magnetic field dose effects in small animals: a Monte Carlo study

Investigating magnetic field dose effects in small animals: a Monte Carlo study
Ashley Erin Rubinstein1, 4, Michele Guindani3, John D Hazle2, Laurence E Court1, 2
1Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
2Departments of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
3Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
4Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, TX, USA.

Cite this article as: Rubinstein A, Guindani M, Hazle JD, Court LE. Investigating magnetic field dose effects in small animals: a Monte Carlo study. Int J Cancer Ther Oncol 2014; 2(2):020233.
DOI:
http://dx.doi.org/10.14319/ijcto.0202.33

Conference Proceeding
[Presented at the Young Investigator’s Symposium at the 2014 Annual Meeting of Southwest Chapter of American Association of Physicists in Medicine (AAPM) in San Antonio, Texas, USA]

Abstract

Purpose: In MRI-linac treatments, radiation dose distributions are affected by magnetic fields, especially at high-density/low-density interfaces. Radiobiological consequences of magnetic field dose effects are presently unknown and preclinical studies are desirable. This study investigates the optimal combination of beam energy and magnetic field strength needed for preclinical murine studies.

Methods: The Monte Carlo code MCNP6 was used to simulate the effects of a magnetic field when irradiating a mouse lung phantom with a 1.0 cm × 1.0 cm photon beam. Magnetic field dose effects were examined using various beam energies (225 kVp, 662 keV [Cs-137], and 1.25MeV [Co-60]) and magnetic field strengths (0.75 T, 1.5 T, and 3 T). The resulting dose distributions were compared to Monte Carlo results for humans with various field sizes and patient geometries using a 6MV/1.5T MRI-linac.

Results: In human simulations, the addition of a 1.5 T magnetic field causes an average dose increase of 49% (range: 36% - 60%) to lung at the soft tissue-lung interface and an average dose decrease of 30% (range: 25% - 36%) at the lung-soft tissue interface. In mouse simulations, no magnetic field dose effects were seen with the 225 kVp beam. The dose increase for the Cs-137 beam was 12%, 33%, and 49% for 0.75 T, 1.5 T, and 3.0 T magnetic fields, respectively while the dose decrease was 7%, 23%, and 33%. For the Co-60 beam the dose increase was 14%, 45%, and 41%, and the dose decrease was 18%, 35%, and 35%.

Conclusion: The magnetic field dose effects observed in mouse phantoms using a Co-60 beam with 1.5 T or 3 T fields or a Cs-137 beam with a 3T field fall within the range seen in humans treated with an MRI-linac. These irradiator/magnet combinations are therefore suitable for preclinical studies investigating potential biological effects of delivering radiation therapy in the presence of a magnetic field.



FIG. 1: Human lung irradiation with a single 6MV beam in the presence of a 1.5T magnetic field using the Monaco treatment planning system. Hot spots and cold spots are seen at tissue boundaries.

Innovation/impact: Before the recently developed 1.5T/6MV MRI-linac can be used clinically, its safety must be assessed. Magnetic fields are known to alter dose deposition by inducing a reduced build-up distance and a laterally shifted, asymmetrical penumbra as well as an effect termed the electron return effect (ERE). Monte Carlo simulations have shown the ERE leads to an increase in dose at the transition from high-density to low-density areas and a decrease in dose when going in the opposite direction. Magnetic field-induced hot spots and cold spots could have potential radiobiological effects. Preclinical experiments should therefore be performed before patients are treated with the MRI-linac. In this study, we determined multiple beam energy/magnetic field combinations that produce dose distributions in the lungs of mice similar to those seen in simulated human treatments with the MRI-linac. These irradiator/magnet combinations can now be used in experiments to investigate magnetic field dose effects in vivo.


FIG. 2: Percent depth dose (PDD) curves along the central axis of the beam in FIG. 1 in the presence and absence of a magnetic field. Doses are relative to Dmax for the 0 T case.


FIG. 3: PDD curves for a 1.25 MeV Co-60 beam with various magnetic fields in a mouse-sized lung phantom. Material was added anteriorly to allow for 5 mm of buildup.


FIG. 4: PDD curves for a 662 keV Cs-137 beam with various magnetic fields in a mouse-sized lung phantom.


Received March 19, 2014; Published Online April 08, 2014

Presenting author: Ashley Erin Rubinstein; Departments of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Copyright © International Journal of Cancer Therapy and Oncology (IJCTO)

Comments on this article

View all comments


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

------------------------------------------------------------

International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)

© International Journal of Cancer Therapy and Oncology (IJCTO)

To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.

------------------------------------------------------------

Number of visits since October, 2013
AmazingCounters.com